Home Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia
Article
Licensed
Unlicensed Requires Authentication

Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia

  • Gözde Akın Kağızmanlı ORCID logo , Özge Besci ORCID logo , Kübra Yüksek Acinikli ORCID logo , Gül Şeker ORCID logo , Elif Yaşar ORCID logo , Yeşim Öztürk ORCID logo , Korcan Demir ORCID logo , Ece Böber ORCID logo and Ayhan Abacı ORCID logo EMAIL logo
Published/Copyright: October 3, 2022

Abstract

Objectives

Large cell calcifying Sertoli cell tumours (LCCSCTs) are one of the infrequent causes of prepubertal gynaecomastia. Most of these tumours are in the content of Peutz–Jeghers syndrome (PJS) or other familial syndromes (Carney complex).

Case presentation

Here, we report a long-term follow-up of an 8.5-year-old prepubertal boy with a diagnosis of PJS, who presented with bilateral gynaecomastia, advanced bone age and accelerated growth velocity, and were found to have bilateral multifocal testicular microcalcifications. As the findings were compatible with LCCSCT, anastrozole was initiated. Gynaecomastia completely regressed and growth velocity and pubertal development were appropriate for age during follow-up. Testicular lesions slightly increased in size. After four years of medication, anastrozole was discontinued but was restarted due to the recurrence of gynaecomastia after six months.

Conclusions

Testicular tumour should be investigated in a patient with PJS who presents with prepubertal gynaecomastia. When findings are consistent with LCCSCT, aromatase inhibitors may be preferred in the treatment.


Corresponding author: Prof. Dr. Ayhan Abacı, Division of Pediatric Endocrinology, Faculty of Medicine, Dokuz Eylul University, Inciraltı-Balcova, İzmir, 35340, Turkey, Phone: +905054776604, Fax: +902324122263, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors contributed to the study conception and design. G.A.K. gathered data and wrote the first draft; O.B. and K.Y.A. gathered data and followed up with the patient; G.S. and Y.O. performed a colonoscopy and treated gastroenterologic involvement; E.Y. performed testicular ultrasound; A.A. edited the paper; and K.D. and E.B. investigated the clinical disorder, made the clinical diagnosis, followed up with the patient, and critically edited the paper. All authors commented on the drafts of the manuscript. All authors read and approved the final manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Ethical approval: Research has been complied with all the relevant national regulations, and institutional policies and in accordance with the World Medical Association Declaration of Helsinki and the appropriate guidelines for human studies.

  5. Informed consent: Written informed consent was obtained from the parents.

  6. Consent for publication: Parents signed informed consent regarding publishing their data. All authors read and approved the final manuscript for publication.

References

1. Narula, HS, Carlson, HE. Gynaecomastia - pathophysiology, diagnosis and treatment. Nat Rev Endocrinol 2014;10:684–98. https://doi.org/10.1038/nrendo.2014.139.Search in Google Scholar PubMed

2. Ma, NS, Geffner, ME. Gynaecomastia in prepubertal and pubertal men. Curr Opin Pediatr 2008;20:465–70. https://doi.org/10.1097/mop.0b013e328305e415.Search in Google Scholar PubMed

3. Simões-Pereira, J, Santos, F, Lopes, L, Limbert, C. Prepubertal gynaecomastia in a boy with Peutz-Jeghers syndrome: managing the aromatase overexpression. J Pediatr Endocrinol Metab 2018;31:1149–54. https://doi.org/10.1515/jpem-2017-0455.Search in Google Scholar PubMed

4. Gourgari, E, Saloustros, E, Stratakis, CA. Large-cell calcifying Sertoli cell tumours of the testes in pediatrics. Curr Opin Pediatr 2012;24:518–22. https://doi.org/10.1097/mop.0b013e328355a279.Search in Google Scholar PubMed PubMed Central

5. Sandru, F, Petca, A, Dumitrascu, M, Petca, RC, Carsote, M. Peutz-Jeghers syndrome: skin manifestations and endocrine anomalies (Review). Exp Ther Med 2021;22:1–7. https://doi.org/10.3892/etm.2021.10823.Search in Google Scholar PubMed PubMed Central

6. Laimon, W, El-Hawary, A, Aboelenin, H, Elzohiri, M, Abdelmaksoud, S, Megahed, N, et al.. Prepubertal gynaecomastia is not always idiopathic: case series and review of the literature. Eur J Pediatr 2021;180:977–82. https://doi.org/10.1007/s00431-020-03799-x.Search in Google Scholar PubMed

7. Yekedüz, MK, Şıklar, Z, Burgu, B, Kuloğlu, Z, Kocaay, P, Çamtosun, E, et al.. Response to anastrozole treatment in a case with Peutz-Jeghers syndrome and a large cell calcifying sertoli cell tumor. J Clin Res Pediatr Endocrinol 2017;9:168–71.10.4274/jcrpe.3625Search in Google Scholar PubMed PubMed Central

8. Tuhan, H, Abaci, A, Sarsık, B, Öztürk, T, Olguner, M, Catli, G, et al.. Intratubular large cell hyalinising Sertoli cell tumour of the testis presenting with prepubertal gynaecomastia: a case report. Acta Clin Belg 2017;72:254–8. https://doi.org/10.1080/17843286.2016.1215869.Search in Google Scholar PubMed

9. Kara, C, Kutlu, AO, Tosun, MS, Apaydin, S, Senel, F. Sertoli cell tumour causing prepubertal gynaecomastia in a boy with Peutz-Jeghers syndrome: the outcome of 1-year treatment with the aromatase inhibitor testolactone. Horm Res 2005;63:252–6. https://doi.org/10.1159/000086325.Search in Google Scholar PubMed

10. Grandone, A, Miraglia Del Giudice, E, Cirillo, G, Santarpia, M, Coppola, F, Perrone, L. Prepubertal gynaecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years’ treatment with anastrozole and genetic study. Horm Res Paediatr 2011;75:374–9. https://doi.org/10.1159/000324178.Search in Google Scholar PubMed

11. Crocker, MK, Gourgari, E, Lodish, M, Stratakis, CA. Use of aromatase inhibitors in large cell calcifying sertoli cell tumours: effects on gynaecomastia, growth velocity, and bone age. J Clin Endocrinol Metab 2014;99:E2673–80. https://doi.org/10.1210/jc.2014-2530.Search in Google Scholar PubMed PubMed Central

Received: 2022-07-23
Accepted: 2022-09-08
Published Online: 2022-10-03
Published in Print: 2022-12-16

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review
  4. Original Articles
  5. Triple burden of malnutrition and role of anaemia in the development of complications associated with type 1 diabetes in Indian children and youth
  6. Effect of obesity and excessive body fat on glycaemic control in paediatric type 1 diabetes
  7. Role of pan immune inflammatory value in the evaluation of hepatosteatosis in children and adolescents with obesity
  8. Secular trends of birth weight and its associations with obesity and hypertension among Southern Chinese children and adolescents
  9. Insights into the implication of obesity in hypogonadism among adolescent boys
  10. The association between plasma carnitines and duration of diabetic ketoacidosis treatment in children with type 1 diabetes
  11. Cathelicidin as a marker for subclinical cardiac changes and microvascular complications in children and adolescents with type 1 diabetes
  12. Developing a risk assessment tool for identifying individuals at high risk for developing insulin resistance in European adolescents: the HELENA-IR score
  13. Hemoglobin A1C can differentiate subjects with GCK mutations among patients suspected to have MODY
  14. Perceptions and use of complementary and alternative medicine in patients with precocious puberty
  15. Case Reports
  16. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus
  17. Heterozygous CDC73 mutation causing hyperparathyroidism in children and adolescents: a report of 2 cases
  18. Wolfram syndrome in a young woman with associated hypergonadotropic hypogonadism – A case report
  19. Continuous glucose monitoring in an infant with panhypopituitarism having hypoglycemia on growth hormone therapy
  20. Severe consumptive hypothyroidism in hepatic hemangioendothelioma
  21. Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0368/html
Scroll to top button